Sarah E Garner

Summary

Affiliation: National Institute for Health and Clinical Excellence
Country: UK

Publications

  1. pmc Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis
    Michael G Wilson
    McMaster Health Forum, McMaster University, Hamilton, Canada
    Syst Rev 3:143. 2014
  2. pmc Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives
    David Uguen
    Voisin Consulting Life Sciences, Paris, France
    Orphanet J Rare Dis 9:20. 2014
  3. doi request reprint Reducing ineffective practice: challenges in identifying low-value health care using Cochrane systematic reviews
    Sarah Garner
    National Institute for Health and Clinical Excellence, London
    J Health Serv Res Policy 18:6-12. 2013
  4. doi request reprint Minocycline for acne vulgaris: efficacy and safety
    Sarah E Garner
    Research and Development, National Institute for Health and Clinical Excellence NICE, London, UK
    Cochrane Database Syst Rev 8:CD002086. 2012

Collaborators

  • Peter Littlejohns
  • Michael G Wilson
  • David Uguen
  • Thomas Lönngren
  • Kaelan A Moat
  • Emmanuelle Voisin
  • Jeremy M Grimshaw
  • Carlo Incerti
  • John N Lavis
  • Roberto Grilli
  • Moriah E Ellen
  • Justin Peffer
  • Kevin Samra
  • Yann Le Cam
  • Ron Goeree
  • Moncef Slaoui
  • Joshua Shemer
  • Marc Dunoyer
  • Terry Sullivan

Detail Information

Publications4

  1. pmc Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis
    Michael G Wilson
    McMaster Health Forum, McMaster University, Hamilton, Canada
    Syst Rev 3:143. 2014
    ....
  2. pmc Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives
    David Uguen
    Voisin Consulting Life Sciences, Paris, France
    Orphanet J Rare Dis 9:20. 2014
    ..This paper presents perspectives on the current and emerging schemes for accelerating development of and access to medicines for rare diseases in the European Union. ..
  3. doi request reprint Reducing ineffective practice: challenges in identifying low-value health care using Cochrane systematic reviews
    Sarah Garner
    National Institute for Health and Clinical Excellence, London
    J Health Serv Res Policy 18:6-12. 2013
    ..Our objective was to use Cochrane Reviews to identify low value practices to support local disinvestment decisions...
  4. doi request reprint Minocycline for acne vulgaris: efficacy and safety
    Sarah E Garner
    Research and Development, National Institute for Health and Clinical Excellence NICE, London, UK
    Cochrane Database Syst Rev 8:CD002086. 2012
    ..A modified-release version of minocycline is being promoted as having fewer side-effects...